Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
Recruiting now
Conditions studied: Bladder Urothelial Carcinoma
In brief
This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).
Key facts
- Study ID
- NCT07029256
- Run by
- Mayo Clinic
- People needed
- 100
- Starts
- 2024-07-26
- Expected to finish
- 2030-07-30
- Last updated by the study team
- 2026-06-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Undergoing radical cystectomy for confirmed or suspected urothelial carcinoma of the bladder
- Prior abdominal imaging
You may not qualify if…
- History of partial cystectomy or complex bladder reconstruction or substitution (i.e. bladder augment or urothelial recurrence in a neobladder)
Where it is running
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.